MedTrace Logo

Effect of Deep Neuromuscular Block on Surgical Conditions in Morbidly Obese Patients

NCT02553629 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2017-02-03

Study results available
· View outcomes & findings →

Summary

This is a randomized control trial (RCT) that studies the surgical conditions during moderate and deep neuromuscular blockade in 100 morbidly obese patients receiving elective laparoscopic surgery for bariatric surgery.

Conditions

  • Surgical Conditions

Interventions

DRUG

Rocuronium

Sponsors & Collaborators

  • Merck Sharp & Dohme LLC

    collaborator INDUSTRY

  • Medical Center Haaglanden

    collaborator OTHER

  • Leiden University Medical Center

    lead OTHER

Principal Investigators

  • Albert Dahan, MD, PhD, professor · LUMC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02553629 on ClinicalTrials.gov